Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 949

1.

Relating the outcome of HCV infection and different host SNP polymorphisms in a Majorcan population coinfected with HCV-HIV and treated with pegIFN-RBV.

Matas M, Picornell A, Cifuentes C, Payeras A, Homar F, González-Candelas F, López-Labrador FX, Moya A, Ramon C, Castro JA.

Int Microbiol. 2014 Mar;17(1):11-20.

PMID:
25296442
[PubMed - indexed for MEDLINE]
2.

Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV.

Odolini S, Amadasi S, Cerini C, Giralda M, Nasta P, Castelli F.

BMC Infect Dis. 2014;14 Suppl 5:S4. doi: 10.1186/1471-2334-14-S5-S4. Epub 2014 Sep 5.

PMID:
25236496
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs.

Royle CM, Graham DR, Sharma S, Fuchs D, Boasso A.

J Immunol. 2014 Oct 1;193(7):3538-48. doi: 10.4049/jimmunol.1400860. Epub 2014 Aug 25.

PMID:
25156368
[PubMed - indexed for MEDLINE]
4.

Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial.

Klein MB, Lee T, Brouillette MJ, Sheehan NL, Walmsley S, Wong DK, Conway B, Hull M, Cooper C, Haidar S, Vezina S, Annable L, Young S, Zubyk W, Singer J.

HIV Clin Trials. 2014 Jul-Aug;15(4):161-75. doi: 10.1310/hct1504-161.

PMID:
25143025
[PubMed - indexed for MEDLINE]
5.

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection.

Saab S, Gordon SC, Park H, Sulkowski M, Ahmed A, Younossi Z.

Aliment Pharmacol Ther. 2014 Sep;40(6):657-75. doi: 10.1111/apt.12871. Epub 2014 Jul 28.

PMID:
25065960
[PubMed - indexed for MEDLINE]
6.

Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.

Sandler NG, Bosinger SE, Estes JD, Zhu RT, Tharp GK, Boritz E, Levin D, Wijeyesinghe S, Makamdop KN, del Prete GQ, Hill BJ, Timmer JK, Reiss E, Yarden G, Darko S, Contijoch E, Todd JP, Silvestri G, Nason M, Norgren RB Jr, Keele BF, Rao S, Langer JA, Lifson JD, Schreiber G, Douek DC.

Nature. 2014 Jul 31;511(7511):601-5. doi: 10.1038/nature13554. Epub 2014 Jul 9.

PMID:
25043006
[PubMed - indexed for MEDLINE]
7.

Antiviral treatment of hepatitis C.

Feeney ER, Chung RT.

BMJ. 2014 Jul 7;348:g3308. doi: 10.1136/bmj.g3308. Review.

PMID:
25002352
[PubMed - indexed for MEDLINE]
Free Article
8.

[Treatment of hepatitis C: current status and perspectives].

Pol S, Corouge M.

Rev Prat. 2014 May;64(5):605-12. French.

PMID:
24923038
[PubMed - indexed for MEDLINE]
9.

Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world setting.

Mandorfer M, Payer BA, Niederecker A, Lang G, Aichelburg MC, Strassl R, Boesecke C, Rieger A, Trauner M, Peck-Radosavljevic M, Reiberger T.

AIDS Patient Care STDS. 2014 May;28(5):221-7. doi: 10.1089/apc.2013.0359.

PMID:
24796757
[PubMed - indexed for MEDLINE]
10.

Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients.

Balagopal A, Kandathil AJ, Higgins YH, Wood J, Richer J, Quinn J, Eldred L, Li Z, Ray SC, Sulkowski MS, Thomas DL.

Hepatology. 2014 Aug;60(2):477-86. doi: 10.1002/hep.27158. Epub 2014 May 14.

PMID:
24706559
[PubMed - indexed for MEDLINE]
11.

Hepatitis C treatment & management.

Andronescu D, Diaconu S, Tiuca N, Purcarea RM, Andronescu CI.

J Med Life. 2014 Mar 15;7(1):31-6. Epub 2014 Mar 25.

PMID:
24653754
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients.

Sagnelli C, Uberti-Foppa C, Galli L, Pasquale G, Coppola N, Albarello L, Doglioni C, Lazzarin A, Sagnelli E.

Braz J Infect Dis. 2014 Mar-Apr;18(2):164-9. doi: 10.1016/j.bjid.2013.06.005. Epub 2013 Oct 25.

PMID:
24650995
[PubMed - indexed for MEDLINE]
Free Article
13.

Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection.

Gentile I, Buonomo AR, Borgia F, Castaldo G, Borgia G.

Expert Opin Investig Drugs. 2014 Apr;23(4):561-71. doi: 10.1517/13543784.2014.892581. Epub 2014 Mar 4. Review.

PMID:
24593285
[PubMed - indexed for MEDLINE]
14.

An update on hepatitis B, D, and E viruses.

Price J.

Top Antivir Med. 2014 Jan;21(5):157-63. Review.

PMID:
24531556
[PubMed - indexed for MEDLINE]
Free Article
15.

Human immunodeficiency virus (HIV)-associated epidermodysplasia verruciformis eradicated after interferon-α and ribavirin treatment.

Javelle E, Lightburne E, Dukan P, De Biasi C, Morand JJ.

Int J Dermatol. 2014 Apr;53(4):487-9. doi: 10.1111/j.1365-4632.2012.05583.x. Epub 2014 Feb 14. No abstract available.

PMID:
24527965
[PubMed - indexed for MEDLINE]
16.

Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management.

Kang W, Tong HI, Sun Y, Lu Y.

Expert Rev Gastroenterol Hepatol. 2014 Mar;8(3):247-66. doi: 10.1586/17474124.2014.876357. Epub 2014 Jan 22. Review.

PMID:
24450362
[PubMed - indexed for MEDLINE]
17.

Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes.

Torres-Cornejo A, Ruiz-Valderas R, Jimenez-Jimenez L, Abad-Molina C, Gutierrez-Valencia A, Viciana P, Lopez-Cortes LF.

J Viral Hepat. 2014 Mar;21(3):178-88. doi: 10.1111/jvh.12128. Epub 2013 Jul 17.

PMID:
24438679
[PubMed - indexed for MEDLINE]
18.

Relative resistance of HIV-1 founder viruses to control by interferon-alpha.

Fenton-May AE, Dibben O, Emmerich T, Ding H, Pfafferott K, Aasa-Chapman MM, Pellegrino P, Williams I, Cohen MS, Gao F, Shaw GM, Hahn BH, Ochsenbauer C, Kappes JC, Borrow P.

Retrovirology. 2013 Dec 3;10:146. doi: 10.1186/1742-4690-10-146.

PMID:
24299076
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[Hepatitis C virus: 25 years-old, the end?].

Pol S.

Med Sci (Paris). 2013 Nov;29(11):998-1003. doi: 10.1051/medsci/20132911016. Epub 2013 Nov 20. Review. French.

PMID:
24280503
[PubMed - indexed for MEDLINE]
Free Article
20.

Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection.

Feld JJ, Grebely J, Matthews GV, Applegate T, Hellard M, Sherker A, Cherepanov V, Petoumenos K, Yeung B, Kaldor JM, Lloyd AR, Dore GJ.

PLoS One. 2013 Nov 20;8(11):e80003. doi: 10.1371/journal.pone.0080003. eCollection 2013.

PMID:
24278230
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk